Inotiv, an Indiana-based non-clinical contract research organization, has acquired the genetic toxicology unit of MilliporeSigma’s BioReliance portfolio. While MilliporeSigma 's parent Merck is headquartered in Germany, it has a Bioreliance facility at 14920 Broschart Road in Rockville. As a result, Inotiv announced plans today to lease space in Rockville near that Bioreliance facility "to help boost its new buy," Fierce Biotech's Ben Adams reported this morning.
Is this where the dogs are being killed?
ReplyDeleteNo
DeleteWe don’t want you here!!! Go away!! Free the dogs your abusing in Indiana!!
ReplyDelete